Shortening the course of antibiotic treatment in the intensive care unit

References

• Bergmans DC, Bonten MJ, Gaillard CA, et al. Indications for antibiotic use in ICU patients: a one-year prospective study. J Antimicrob Chemother 1997;39:527-35
   PubMed Web of Science ®Google Scholar
• Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302(21):2323-9
   PubMed Web of Science ®Google Scholar
• Montravers P, Dupont H, Gauzit R, et al. Strategies of initiation and streamlining of antibiotic therapy in 41 French intensive care units. Crit Care 2011;15:R17
   PubMed Web of Science ®Google Scholar
• Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41(2):580-637
   PubMed Web of Science ®Google Scholar
• Masterton RG, Galloway A, French G, et al. Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2008;62(1):5-34
   PubMed Web of Science ®Google Scholar
• American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171(4):388-416
   PubMed Web of Science ®Google Scholar
• Tenke P, Kovacs B, Bjerklund Johansen TE, et al. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents 2008;31(Suppl 1):S68-78
   PubMedGoogle Scholar
• Hooton TM, Bradley SF, Cardenas DD, et al. Infectious Diseases Society of America: diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010;50(5):625-63
   PubMed Web of Science ®Google Scholar
• Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010;50(2):133-64. Erratum in Clin Infect Dis 2010;50(12):1695
   PubMed Web of Science ®Google Scholar
• Corona A, Bertolini G, Ricotta AM, et al. Variability of treatment duration for bacteraemia in the critically ill: a multinational survey. J Antimicrob Chemother 2003;52(5):849-52
   PubMed Web of Science ®Google Scholar
• Ibrahim EH, Ward S, Sherman G, et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001;29(6):1109-15
   PubMed Web of Science ®Google Scholar
• Corona A, Wilson APR, Grassi M, Singer M. Short-course monotherapy strategy for treating bacteremia in the critically ill. Minerva Anestesiol 2006;72(10):841-57
   PubMed Web of Science ®Google Scholar
• Edgeworth JD, Chis Ster I, Wyncoll D, et al. Long-term adherence to a 5 day antibiotic course guideline for treatment of intensive care unit (ICU)-associated Gram-negative infections. J Antimicrob Chemother 2014;69(6):1688-94
   PubMed Web of Science ®Google Scholar
• Kenneally C, Rosini JM, Skrupky LP, et al. Analysis of 30-day mortality for Clostridium difficile-associated disease in the ICU setting. Chest 2007;132(2):418-24
   PubMed Web of Science ®Google Scholar
• Ghantoji SS, Sail K, Lairson DR, et al. Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect 2010;74(4):309-18
   PubMed Web of Science ®Google Scholar
• de Kraker ME, Jarlier V, Monen JC, et al. The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. Clin Microbiol Infect 2013;19(9):860-8
   PubMed Web of Science ®Google Scholar
• Nasa P, Juneja D, Singh O, et al. An observational study on bloodstream extended-spectrum beta-lactamase infection in critical care unit: incidence, risk factors and its impact on outcome. Eur J Intern Med 2012;23(2):192-5
   PubMed Web of Science ®Google Scholar
• Du B, Long Y, Liu H, et al. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med 2002;28(12):1718-23
   PubMed Web of Science ®Google Scholar
• Jain A, Hopkins KL, Turton J, et al. NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases. J Antimicrob Chemother 2014;69(7):1777-84
   PubMed Web of Science ®Google Scholar
• Annual Report of the Chief Medical Officer 2011. Volume 2. Available from: www.gov.uk/government/publications/chief-medical-officer-annual-report-volume-2
   Google Scholar
• Montravers P, Fagon JY, Chastre J, et al. Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am Rev Respir Dis 1993;147(1):38-44
   PubMedGoogle Scholar
• Dennesen PJ, van der Ven AJ, Kessels AG, et al. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 2001;163(6):1371-5
   PubMed Web of Science ®Google Scholar
• Luna CM, Blanzaco D, Niederman MS, et al. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 2003;31(3):676-82
   PubMed Web of Science ®Google Scholar
• Alberti C, Brun-Buisson C, Burchardi H, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002;28(2):108-21
   PubMed Web of Science ®Google Scholar
• Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003;290(19):2588-98
   PubMed Web of Science ®Google Scholar
• Pugh RJ, Cooke RP, Dempsey G. Short course antibiotic therapy for Gram-negative hospital-acquired pneumonia in the critically ill. J Hosp Infect 2010;74(4):337-43
   PubMed Web of Science ®Google Scholar
• Hedrick TL, McElearney ST, Smith RL, et al. Duration of antibiotic therapy for ventilator-associated pneumonia caused by non-fermentative gram-negative bacilli. Surg Infect Larchmt 2007;8(6):589-97
   PubMedGoogle Scholar
• Pugh R, Grant C, Cooke RP, Dempsey G. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults. Cochrane Database Syst Rev 2011;10:CD007577
   PubMed Web of Science ®Google Scholar
• Dimopoulos G, Poulakou G, Pneumatikos IA, et al. Short- vs long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis. Chest 2013;144(6):1759-67
   PubMed Web of Science ®Google Scholar
• Tao L, Hu B, Rosenthal VD, et al. Device-associated infection rates in 398 intensive care units in Shanghai, China: international Nosocomial Infection Control Consortium (INICC) findings. Int J Infect Dis 2011;15(11):e774-80
   PubMed Web of Science ®Google Scholar
• Havey TC, Fowler RA, Pinto R, et al. Duration of antibiotic therapy for critically ill patients with bloodstream infections: a retrospective cohort study. Can J Infect Dis Med Microbiol 2013;24(3):129-37
   PubMed Web of Science ®Google Scholar
• Havey TC, Fowler RA, Daneman N. Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis. Crit Care 2011;15(6):R267
   PubMed Web of Science ®Google Scholar
• Basoli A, Chirletti P, Cirino E, et al. A prospective, double-blind, multicenter, randomized trial comparing ertapenem 3 vs >or=5 days in community-acquired intraabdominal infection. J Gastrointest Surg 2008;12(3):592-600
   PubMed Web of Science ®Google Scholar
• Scawn N, Saul D, Pathak D, et al. A pilot randomised controlled trial in intensive care patients comparing 7 days’ treatment with empirical antibiotics with 2 days’ treatment for hospital-acquired infection of unknown origin. Health Technol Assess 2012;16(36):i-xiii; 1-70
   PubMed Web of Science ®Google Scholar
• Finfer S, Bellomo R, Lipman J, et al. Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med 2004;30(4):589-96
   PubMed Web of Science ®Google Scholar
• Singh N, Rogers P, Atwood CW, et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000;162(2 Pt 1):505-11
   PubMed Web of Science ®Google Scholar
• Marshall JC, Maier RV, Jimenez M, Dellinger EP. Source control in the management of severe sepsis and septic shock: an evidence-based review. Crit Care Med 2004;32(11 Suppl):S513-26
   PubMedGoogle Scholar
• Boyer A, Vargas F, Coste F, et al. Influence of surgical treatment timing on mortality from necrotizing soft tissue infections requiring intensive care management. Intensive Care Med 2009;35(5):847-53
   PubMed Web of Science ®Google Scholar
• Moss RL, Musemeche CA, Kosloske AM. Necrotizing fasciitis in children: prompt recognition and aggressive therapy improve survival. J Pediatr Surg 1996;31(8):1142-6
   PubMed Web of Science ®Google Scholar
• Jimenez MF, Marshall JC. International Sepsis Forum. Source control in the management of sepsis. Intensive Care Med 2001;27(Suppl 1):S49-62
   PubMedGoogle Scholar
• Puig-Asensio M, Pemán J, Zaragoza R, et al. Impact of therapeutic strategies on the prognosis of candidemia in the ICU. Crit Care Med 2014;42(6):1423-32
   PubMed Web of Science ®Google Scholar
• Hawkins C, Huang J, Jin N, et al. Persistent Staphylococcus aureus bacteremia: an analysis of risk factors and outcomes. Arch Intern Med 2007;167(17):1861-7
   PubMedGoogle Scholar
• Yoon YK, Kim JY, Park DW, et al. Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin. J Antimicrob Chemother 2010;65(5):1015-18
   PubMed Web of Science ®Google Scholar
• Pea F, Viale P. Bench-to-bedside review: appropriate antibiotic therapy in severe sepsis and septic shock – does the dose matter? Critical Care 2009;13(3):article 214
   PubMed Web of Science ®Google Scholar
• Roberts JA, Paul SK, Akova M, et al. DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 2014;58(8):1072-83
   PubMed Web of Science ®Google Scholar
• Kollef MH. Optimizing antibiotic therapy in the intensive care unit setting. Crit Care 2001;5(4):189-95
   PubMed Web of Science ®Google Scholar
• Roberts JA, Roberts MS, Semark A, et al. Antibiotic dosing in the ‘at risk’ critically ill patient: linking pathophysiology with pharmacokinetics/pharmacodynamics in sepsis and trauma patients. BMC Anesthesiol 2011;11:3
   PubMed Web of Science ®Google Scholar
• Herrera-Gutiérrez ME, Seller-Pérez G, Sánchez-Izquierdo-Riera JA, et al. Prevalence of acute kidney injury in intensive care units: the “COrte de prevalencia de disFunción RenAl y DEpuración en críticos” point-prevalence multicenter study. J Crit Care 2013;28(5):687-94
   PubMed Web of Science ®Google Scholar
• Hoste EA, Schurgers M. Epidemiology of acute kidney injury: how big is the problem? Crit Care Med 2008;36(4 Suppl):S146-51
   PubMed Web of Science ®Google Scholar
• Claus BO, Hoste EA, Colpaert K, et al. Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy. J Crit Care 2013;28(5):695-700
   PubMed Web of Science ®Google Scholar
• Udy AA, Roberts JA, Lipman J. Clinical implications of antibiotic pharmacokinetic principles in the critically ill. Intensive Care Med 2013;39(12):2070-82
   PubMed Web of Science ®Google Scholar
• Roberts JA, Webb S, Paterson D, et al. A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics. Crit Care Med 2009;37(6):2071-8
   PubMed Web of Science ®Google Scholar
• Lodise TPJr, Lomaestro B, Drusano GL. Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy. Clin Infect Dis 2007;44(3):357-63
   PubMed Web of Science ®Google Scholar
• Osmon DR, Berbari EF, Berendt AR, et al. Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013;56(1):1-10
   PubMed Web of Science ®Google Scholar
• Dupont H, Carbon C, Carlet J. Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group. Antimicrob Agents Chemother 2000;44(8):2028-33
   PubMed Web of Science ®Google Scholar
• Aarts MA, Hancock JN, Heyland D, et al. Empiric antibiotic therapy for suspected ventilator-associated pneumonia: a systematic review and meta-analysis of randomized trials. Crit Care Med 2008;36(1):108-17
   PubMed Web of Science ®Google Scholar
• Heyland DK, Dodek P, Muscedere J, et al. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Crit Care Med 2008;36(3):737-44
   PubMed Web of Science ®Google Scholar
• Tanimoto K, Tomita H, Fujimoto S, et al. Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation. Antimicrob Agents Chemother 2008;52:3795-800
   PubMed Web of Science ®Google Scholar
• Kumar A, Zarychanski R, Light B, et al. Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Crit Care Med 2010;38(9):1773-85
   PubMed Web of Science ®Google Scholar
• Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009;30(19):2369-413
   PubMed Web of Science ®Google Scholar
• Díaz-Martín A, Martínez-González ML, Ferrer R, et al. Antibiotic prescription patterns in the empiric therapy of severe sepsis: combination of antimicrobials with different mechanisms of action reduces mortality. Crit Care 2012;16(6):R223
   PubMed Web of Science ®Google Scholar
• Kumar A, Safdar N, Kethireddy S, Chateau D. A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study. Crit Care Med 2010;38(8):1651-64
   PubMed Web of Science ®Google Scholar
• Paul M, Lador A, Grozinsky-Glasberg S, Leibovici L. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Syst Rev 2014;1:CD003344
   PubMed Web of Science ®Google Scholar
• Kristensen B, Smedegaard HH, Pedersen HM, et al. Antibiotic resistance patterns among blood culture isolates in a Danish county 1981-1995. J Med Microbiol 1999;48(1):67-71
   PubMed Web of Science ®Google Scholar
• Roberts DM, Roberts JA, Roberts MS, et al. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study. Crit Care Med 2012;40(5):1523-8
   PubMed Web of Science ®Google Scholar
• Beumier M, Casu GS, Hites M, et al. β-Lactam antibiotic concentrations during continuous renal replacement therapy. Crit Care 2014;18(3):R105
   PubMed Web of Science ®Google Scholar
• Roberts JA, Ulldemolins M, Roberts MS, et al. Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept. Int J Antimicrob Agents 2010;36(4):332-9
   PubMed Web of Science ®Google Scholar
• De Waele JJ, Carrette S, Carlier M, et al. Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial. Intensive Care Med 2014;40(3):380-7
   PubMed Web of Science ®Google Scholar
• Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994;79(6):1605-8
   PubMed Web of Science ®Google Scholar
• Uzzan B, Cohen R, Nicolas P, et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006;34(7):1996-2003
   PubMed Web of Science ®Google Scholar
• Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006;174(1):84-93
   PubMed Web of Science ®Google Scholar
• Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 2013;13(5):426-35
   PubMed Web of Science ®Google Scholar
• Jensen JU, Hein L, Lundgren B, et al. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med 2011;39(9):2048-58
   PubMed Web of Science ®Google Scholar
• Reynolds SC, Shorr AF, Muscedere J, et al. Longitudinal changes in procalcitonin in a heterogeneous group of critically ill patients. Crit Care Med 2012;40:2781-7
   PubMed Web of Science ®Google Scholar
• Kopterides P, Siempos II, Tsangaris I, et al. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med 2010;38(11):2229-41
   PubMed Web of Science ®Google Scholar
• Prkno A, Wacker C, Brunkhorst FM, Schlattmann P. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis. Crit Care 2013;17(6):R291
   PubMed Web of Science ®Google Scholar